Forteo, also known under the generic name teriparatide, is marketed by Eli Lilly to re-grow bone in osteoporosis patients. In fact, it is the only FDA approved drug of its type. Soon, however, the FDA may approve Forteo for the treatment of bone loss in gum disease patients. People who have gum disease are known to experience bone loss around the affected gums in the mid to late stage of periodontal disease. Gum disease is the leading cause of tooth […]
Read More
